Lobbying Filing Details
Total Spending
$60,000
Activities
1
Lobbyists
2
Gov't Entities
2
Filing Information
- Filing UUID:
48d02fb4-216c-4a09-bbf3-5a49815a2559- Type:
- Q1 - 1st Quarter - Report
- Period:
- 2026 - 1st Quarter (Jan 1 - Mar 31)
- Date Posted:
- April 20, 2026 at 2:07 PM
- Income:
- $60,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Brian Pomper
Registrant
AKIN GUMP STRAUSS HAUER & FELD
Law firm
WASHINGTON, District of ColumbiaClient
KYVERNA THERAPEUTICS, INC.
Biopharmaceutical company focused on developing cell therapies for autoimmune diseases.
California, United States of AmericaLobbying Activities (1)
Activity 1
Health IssuesIssues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and Multiple Sclerosis; Issues related to appropriations report language for Fiscal Year 2027.
Lobbyists (2)
- ANNA ABRAM
- KANDIS MCCLURE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES